A Yu Elizarova Selected Research

Therapeutics

1/2021

Binding of lactoferrin to the surface of low-density lipoproteins modified by myeloperoxidase prevents intracellular cholesterol accumulation by human blood monocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Yu Elizarova Research Topics

Disease

1	COVID-19 01/2023
1	Infections 01/2023
1	Obesity 01/2021
1	Atherosclerosis 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Multiple Sclerosis 01/2018
1	Necrosis 01/2018
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018

Drug/Important Bio-Agent (IBA)

2	LactoferrinIBA 01/2023 - 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	ferristatin IIIBA 01/2023
1	LigandsIBA 01/2023
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2023
1	IronIBA 01/2023
1	Transferrin (beta 2 Transferrin)IBA 01/2023
1	low density lipoprotein inhibitorIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	RotenoneIBA 01/2018

Therapy/Procedure

1	Therapeutics 01/2021
1	Intraperitoneal Injections 01/2018